» Articles » PMID: 29497773

Luteolin Activates ERK1/2- and Ca-dependent HO-1 Induction That Reduces LPS-induced HMGB1, INOS/NO, and COX-2 Expression in RAW264.7 Cells and Mitigates Acute Lung Injury of Endotoxin Mice

Overview
Journal Inflamm Res
Date 2018 Mar 3
PMID 29497773
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Although luteolin has shown to have anti-inflammatory action, no report is available whether luteolin inhibits HMGB1 and protects acute lung injury (ALI) in endotoxin rodents. We hypothesized that HO-1 induction by luteolin might play a crucial role for inhibition of pro-inflammatory mediators including HMGB1 through MAPK signaling in LPS-induced RAW264.7 cells, and it ameliorates ALI of endotoxin mice.

Methods: The effects of luteolin on the production of pro-inflammatory mediators in LPS-activated RAW264.7 cells and LPS-injected mice were evaluated. The mechanisms were investigated using various signal inhibitors.

Results: Luteolin significantly increased HO-1 expression through ERK1/2 signaling in a time- and concentration-dependent manner. Indeed, luteolin inhibited pro-inflammatory mediators (HMGB1, iNOS/NO, COX-2, and NF-κB activity) in LPS-activated RAW264.7 cells. In addition, PD98059, an ERK1/2 inhibitor, treatment failed to inhibit production of these pro-inflammatory mediators by luteolin. Interestingly, luteolin augmented HO-1 induction through Ca influx in RAW264.7 cells. Administration of luteolin significantly inhibited plasma HMGB1 level, and iNOS expression in the lung that resulted in a significant reduction of ALI in endotoxin mice that was reversed by a HO-1 inhibitor, ZnPPIX.

Conclusion: Therefore, we conclude that luteolin has a great potential for treatment of ALI and related diseases, where HMGB1 is a therapeutic target.

Citing Articles

Natural Compounds Regulate Macrophage Polarization and Alleviate Inflammation Against ALI/ARDS.

Yin Z, Song R, Yu T, Fu Y, Ding Y, Nie H Biomolecules. 2025; 15(2).

PMID: 40001495 PMC: 11853067. DOI: 10.3390/biom15020192.


Cinnamaldehyde Alleviates Alveolar Epithelial Cell Injury in ALI by Inhibiting the CaMKII Pathway.

Liu L, Zhang H, Chen S, Dian W, Zheng Z Cell Biochem Biophys. 2024; 83(1):1097-1104.

PMID: 39316262 DOI: 10.1007/s12013-024-01544-x.


Network pharmacology- and molecular docking-based investigation on the mechanism of action of Si-ni San in the treatment of depression combined with anxiety and experimental verification in adolescent rats.

Li Z, Liang S, Cui X, Shen C, Xu Z, Chen W Front Psychiatry. 2024; 15:1414242.

PMID: 39247617 PMC: 11378754. DOI: 10.3389/fpsyt.2024.1414242.


Exploring the anti-inflammatory ingredients and potential of golden buckwheat () on the TLR4/NLRP3 pathway in acute lung injury.

Hu Y, Liu X, Song Y, Zhang Y, Li W, Zhang L Food Sci Nutr. 2024; 12(8):5426-5441.

PMID: 39139945 PMC: 11317744. DOI: 10.1002/fsn3.4193.


Lonicera japonica Thunb extract ameliorates lipopolysaccharide-induced acute lung injury associated with luteolin-mediated suppression of NF-κB signaling pathway.

Jia Q, Wen J, Yang Q, Liu S, Zhang J, Wang T J Inflamm (Lond). 2023; 20(1):44.

PMID: 38115057 PMC: 10729360. DOI: 10.1186/s12950-023-00372-9.


References
1.
Johnson G, Lapadat R . Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002; 298(5600):1911-2. DOI: 10.1126/science.1072682. View

2.
Tsoyi K, Nizamutdinova I, Jang H, Mun L, Kim H, Seo H . Carbon monoxide from CORM-2 reduces HMGB1 release through regulation of IFN-β/JAK2/STAT-1/INOS/NO signaling but not COX-2 in TLR-activated macrophages. Shock. 2010; 34(6):608-14. DOI: 10.1097/SHK.0b013e3181e46f15. View

3.
Qian X, Numata T, Zhang K, Li C, Hou J, Mori Y . Transient receptor potential melastatin 2 protects mice against polymicrobial sepsis by enhancing bacterial clearance. Anesthesiology. 2014; 121(2):336-51. DOI: 10.1097/ALN.0000000000000275. View

4.
Stevens N, Chapman M, Fraser C, Kuchel T, Hayball J, Diener K . Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes. Sci Rep. 2017; 7(1):5850. PMC: 5517568. DOI: 10.1038/s41598-017-06205-z. View

5.
Liu C, Lin H, Yang D, Chen S, Tseng J, Chang T . Luteolin inhibits viral-induced inflammatory response in RAW264.7 cells via suppression of STAT1/3 dependent NF-κB and activation of HO-1. Free Radic Biol Med. 2016; 95:180-9. DOI: 10.1016/j.freeradbiomed.2016.03.019. View